In early 2019, the American Society of Health-System Pharmacists (ASHP) reported a nationwide shortage of certain intravenous immunoglobulin (IVIG) therapies, which has now led to national shortages of all IVIG products. Supply limitations have affected all healthcare providers who administer these therapies, including IVX Health. At this time, IVX Health is unable to accept new IVIG patients.
IVX Health will continue to accommodate existing patients but cannot guarantee product availability. To proactively inquire about a previously scheduled IVIG appointment, please contact your local center.
Intravenous immunoglobulin, commonly known as IVIG, is a category of infusion therapies that are indicated to treat a variety of conditions, including:
- Primary immunodeficiency diseases
- Immune thrombocytopenia
- Kawasaki disease
- Guillain-Barre syndrome
- Chronic inflammatory demyelinating polyneuropathy
- Other rare diseases
- Neurological diseases like myasthenia gravis or multiple sclerosis
- People who receive bone marrow transplants may also use IVIg to prevent infections.
IVIG products are derived from human plasma, and the need for plasma-derived products grows each year. Commonly prescribed IVIG treatments include:
- And others
Patients chose IVX Health to receive their ongoing IVIG treatments because:
- ALL private suites
- Comfortable recliners, with chairs for guests
- Evening & weekend appointments
- Friendly clinical staff deliver personal service
- Big screen TVs, high-speed WiFi, free snacks